PUBLISHER: Kalorama Information | PRODUCT CODE: 1274859
PUBLISHER: Kalorama Information | PRODUCT CODE: 1274859
What's the size of the service market for clinical testing? What type of tests are selling? Where is this market going next five years? Which companies will earn those revenues? Where is growth coming from? How will LDT regulation affect the market? What are companies planning with COVID-19 largely endemic?
These questions and more are answered in Kalorama's Clinical Laboratory Services report. laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more.
‘Clinical Laboratory Services Market, 8th Edition’ provides an overview of the clinical laboratory industry and the trends driving growth.
Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies.
The laboratory services market is covered by specialty, including:
The clinical lab test is competitive in hospitals, reference laboratories, and in physician office labs and clinics. This report covers all of these markets. A global market analysis by laboratory type is also displayed, including:
Clinical lab tests are sold worldwide. Information is presented as a global focused market report, with key regions discussed including:
Also included is a competitive analysis of leading clinical laboratory providers.
All market data pertains to the world market at the manufacturers' level. The base year for data is 2021. Historical data is provided for the years 2011 through 2020, with forecast data provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for the 2021-2026 periods for each segment covered. A U.S. competitive analysis is provided for the year 2021. The forecasted market analysis through 2026 was largely based on demographic trends, disease trends, new developments, company performance trends, merger and acquisitions, and national expansion.
Among the scores of tables included in this report the following information is provided:
Many of Kalorama's IVD manufacturer customers have found this annual review of the clinical labs market essential. Clinical laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Clinical laboratories are an essential part of the health industry.
In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. In oncology indications, clinical laboratory services are involved in 100% of patient care plans. Hospital and independent laboratories were the two listed types of laboratories for several years with hospitals accounting for approximately 90% of laboratory facilities.
Today, there is a shift in healthcare utilization primarily due to reducing healthcare spending, which makes the laboratory an even more valuable part of the treatment plan. In efforts to reduce health-related costs, hospitals have been striving to reduce length of stays. Although stays in U.S. hospitals were thought to have declined to about 4.3 days on average there has been some indication of an increase among some demographics in recent years. In recent years, the average length of hospital stay has been estimated at around 4.7 days. To continue to try and keep stays at a minimum and ultimately reduce cost, monitoring technologies, diagnostic imaging and laboratory measures and disease/treatment monitoring through diagnostic laboratory practices are primary ways physicians and administrators are continuing to meet optimal healthcare outcomes while also reduce costs.
Global markets are also feeling pressures to reduce health spending. The length of stay on a global level is estimated at 6.6 days on average with Russia and Japan among the higher days of hospitalization. We can expect to see a consolidation in the number of clinical laboratories, particularly in the independent and community sectors, as these trends continue to influence the industry and add pressure to smaller clinical laboratories in an effort to reduce costs and still provide adequate healthcare.